Unknown

Dataset Information

0

Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs.


ABSTRACT: Target-specific genome editing, using engineered nucleases zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and type II clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), is considered a promising approach to correct disease-causing mutations in various human diseases. In particular, hemophilia A can be considered an ideal target for gene modification via engineered nucleases because it is a monogenic disease caused by a mutation in coagulation factor VIII (FVIII), and a mild restoration of FVIII levels in plasma can prevent disease symptoms in patients with severe hemophilia A. In this study, we describe a universal genome correction strategy to restore FVIII expression in induced pluripotent stem cells (iPSCs) derived from a patient with hemophilia A by the human elongation factor 1 alpha (EF1?)-mediated normal FVIII gene expression in the FVIII locus of the patient. We used the CRISPR/Cas9-mediated homology-directed repair (HDR) system to insert the B-domain deleted from the FVIII gene with the human EF1? promoter. After gene targeting, the FVIII gene was correctly inserted into iPSC lines at a high frequency (81.81%), and these cell lines retained pluripotency after knock-in and neomycin resistance cassette removal. More importantly, we confirmed that endothelial cells from the gene-corrected iPSCs could generate functionally active FVIII protein from the inserted FVIII gene. This is the first demonstration that the FVIII locus is a suitable site for integration of the normal FVIII gene and can restore FVIII expression by the EF1? promoter in endothelial cells differentiated from the hemophilia A patient-derived gene-corrected iPSCs.

SUBMITTER: Sung JJ 

PROVIDER: S-EPMC6470126 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs.

Sung Jin Jea JJ   Park Chul-Yong CY   Leem Joong Woo JW   Cho Myung Soo MS   Kim Dong-Wook DW  

Experimental & molecular medicine 20190417 4


Target-specific genome editing, using engineered nucleases zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and type II clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), is considered a promising approach to correct disease-causing mutations in various human diseases. In particular, hemophilia A can be considered an ideal target for gene modification via engineered nucleases because it is a monogenic disease  ...[more]

Similar Datasets

| S-EPMC7905062 | biostudies-literature
| S-EPMC6610636 | biostudies-literature
| S-EPMC10143348 | biostudies-literature
| S-EPMC6397061 | biostudies-literature
| S-EPMC7786582 | biostudies-literature
| S-EPMC4705535 | biostudies-literature
| S-EPMC6894946 | biostudies-literature
| S-EPMC4775845 | biostudies-other
| S-EPMC3480729 | biostudies-literature
| S-EPMC5413600 | biostudies-literature